Guido Alberto Massimo Tiberio

14PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 27, 2026
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma.

Guido Alberto Massimo Tiberio, Giovanni Casole, Deborah Cosentini

|Mar 05, 2026
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.

Francesco Dondi, Davide Lorenzo Bettini, Deborah Cosentini

|Jan 14, 2026
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma.

Marta Laganà, Sara Rodella, Davide Lorenzo Bettini

|Jan 11, 2024
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.

Maria Bencivenga, Silvia Ministrini, Paolo Morgagni

|Sep 28, 2023
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Antonella Turla, Marta Laganà, Andrea Abate

|Sep 28, 2023
Correction: Sigala et al. A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. Cells 2022, 11, 1439.

Sandra Sigala, Christina Bothou, David Penton

Pageof 3

Frequent Collaborators

11 joint publications

Sandra Sigala

5 joint publications

Alfredo Berruti

5 joint publications

Salvatore Grisanti

4 joint publications

Alfredo Berruti